Literature DB >> 19226656

Ketamine/xylazine anesthesia alters [11C]MNPA binding to dopamine D2 receptors and response to methamphetamine challenge in monkey brain.

Hiroyuki Ohba1, Norihiro Harada, Shingo Nishiyama, Takeharu Kakiuchi, Hideo Tsukada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226656     DOI: 10.1002/syn.20632

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


× No keyword cloud information.
  10 in total

Review 1.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

Review 2.  Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?

Authors:  Mette Skinbjerg; David R Sibley; Jonathan A Javitch; Anissa Abi-Dargham
Journal:  Biochem Pharmacol       Date:  2011-09-16       Impact factor: 5.858

3.  Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.

Authors:  Patrick Neil McCormick; Nathalie Ginovart; Alan A Wilson
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

4.  Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.

Authors:  Shigeyuki Yamamoto; Hiroyuki Ohba; Shingo Nishiyama; Norihiro Harada; Takeharu Kakiuchi; Hideo Tsukada; Edward F Domino
Journal:  Neuropsychopharmacology       Date:  2013-07-24       Impact factor: 7.853

5.  A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.

Authors:  Rajesh Narendran; N Scott Mason; Charles M Laymon; Brian J Lopresti; Natalie D Velasquez; Maureen A May; Steve Kendro; Diana Martinez; Chester A Mathis; W Gordon Frankle
Journal:  J Pharmacol Exp Ther       Date:  2010-01-26       Impact factor: 4.030

6.  Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor.

Authors:  Mikael Palner; Corinne Beinat; Sam Banister; Francesca Zanderigo; Jun Hyung Park; Bin Shen; Trine Hjoernevik; Jae Ho Jung; Byung Chul Lee; Sang Eun Kim; Lawrence Fung; Frederick T Chin
Journal:  EJNMMI Res       Date:  2016-11-08       Impact factor: 3.138

7.  Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain.

Authors:  Kai-Chun Yang; Vladimir Stepanov; Stefan Martinsson; Anders Ettrup; Akihiro Takano; Gitte M Knudsen; Christer Halldin; Lars Farde; Sjoerd J Finnema
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

8.  Differential effects of D-cycloserine and amantadine on motor behavior and D2/3 receptor binding in the nigrostriatal and mesolimbic system of the adult rat.

Authors:  Susanne Nikolaus; Hans-Jörg Wittsack; Frithjof Wickrath; Anja Müller-Lutz; Hubertus Hautzel; Markus Beu; Christina Antke; Eduards Mamlins; Maria Angelica De Souza Silva; Joseph P Huston; Gerald Antoch; Hans-Wilhelm Müller
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

Review 9.  Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.

Authors:  Vladimir Shalgunov; Aren van Waarde; Jan Booij; Martin C Michel; Rudi A J O Dierckx; Philip H Elsinga
Journal:  Med Res Rev       Date:  2018-11-18       Impact factor: 12.944

10.  Test-Retest Repeatability of [18F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function.

Authors:  Lara García-Varela; David Vállez García; Manuel Rodríguez-Pérez; Aren van Waarde; Jürgen W A Sijbesma; Anna Schildt; Chantal Kwizera; Pablo Aguiar; Tomás Sobrino; Rudi A J O Dierckx; Philip H Elsinga; Gert Luurtsema
Journal:  ACS Chem Neurosci       Date:  2020-02-03       Impact factor: 4.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.